Drugs – Page 2 – Neuroscience

“Miracle” drugs for weight loss linked to serious digestive problems – PsyBlog

October 28, 2023 by Wilma

These weight loss medications have been shown to increase the risk of pancreatitis and other serious digestive disorders. These weight loss medications have been shown to increase the risk of pancreatitis and other serious digestive disorders. Semaglutide (Wegovy, Ozempic, and Rybelsu) and liraglutide (Victoza and Saxenda) are GLP-1 agonist drugs… Continue Reading “Miracle” drugs for weight loss linked to serious digestive problems – PsyBlog

Weight-loss drugs are safe if used correctly, West Palm Beach doctor says

October 21, 2023 by Wilma

WEST PALM BEACH, Florida. The Journal of the American Medical Association reports that some of the most popular medications available for weight loss, including Ozempic, Wegovy, and Saxenda, may be linked to an increased risk of serious stomach problems in some people. The research was published earlier this month and… Continue Reading Weight-loss drugs are safe if used correctly, West Palm Beach doctor says

Can weight loss drugs save the aviation industry (some money)?

October 20, 2023 by Wilma

Stay informed with free updates Simply register at Pharmaceutical sector myFT Digest – delivered straight to your inbox. Alphaville has received a LOT of research on stocks related to the impact of weight loss drugs such as Ozempic* and Wegovy (mainFT has a great overview here). As the power of… Continue Reading Can weight loss drugs save the aviation industry (some money)?

1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool

October 14, 2023 by Wilma

Weight loss medications have grown in popularity in recent years. People even use a drug like Ozempic, although it is only approved for diabetes, simply because it helps them lose weight. In the last three months of 2022 alone, more than 9 million prescriptions for weight loss drugs were dispensed… Continue Reading 1 Big risk facing Ozempic, Wegovy and other GLP-1 weight loss drugs | The motley fool

Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases

October 11, 2023 by Wilma

Eye-popping predictions for weight-loss drug sales hinge on insurance companies agreeing to provide coverage for expensive treatments, and momentum appears to be building on that front. But Allen Lutz, an analyst at Bank of America, wonders if employers know how risky the bet they’re making is. The hope is that… Continue Reading Bank of America Sees Risks for Employers as Insurance Coverage of Weight Loss Drugs Increases